14th ESC Congress

The 14th ESC Congress “Contraception: from molecular biology to social science and politics’ was held in Basel, 4-7 May 2016

To view a powerpoint presentation click on the title of the presentation.

All abstracts are available in the Book of Abstracts.

Take home messages

Take home messages

Keynote Lectures

Sexual and reproductive rights • R. Khosla (WHO)
The history of syphilis – lessons learned? J.J. Amy (Belgium)

Keynote sessions

Endometrial contraception • K. Gemzell Danielsson (Sweden)
Permanent non-surgical contraceptive methods for women • J. Jensen (USA)
The collaboration between EBCOG and UEMS • R. Kirschner (Norway)

Congress sessions

Congress session 1: Demography
Demographic trends in Europe relative to contraceptive use • D. Archer (USA)
Congress Session 2: Vulnerable groups
Gaps in reproductive and maternal health: the challenge of inequality • R. Schiavon (Mexico)
Unsafe abortion in Thailand • K. Chaturachinda (Thailand)
Reproductive health care for asylum-seeking women • S. Tschudin (Switzerland)
Reproductive health in young Mexican women • J. Lira (Mexico)
Congress session 3: Contraception in high-risk patients 

Contraception in HIV-positive women • B. Zilaitiene (Lithuania)
Contraception in women with headaches and migraine • A. MacGregor (UK)
Contraception in BRCA1/BRCA2-positive women • G. Merki (Switzerland) 
Contraception and PCO • Ø. Lidegaard (Denmark)
Congress session 4: New molecules, applications (and regimens)
Estradiol • A. Mueck (Germany)
Continuous regimen • C. Guazzelli (Brazil) 
Estetrol • J.M. Foidart (Belgium) 
E4 and the breast • C. Verhoeven (the Netherlands)
Congress session 5: Contraception and behavioural science 
Contraception as a behaviour: models of understanding • J. Bitzer (Switzerland) Compliance – blame the women? • A. Kubba (UK)
Congress session 6: Cardiovascular risks of hormonal contraception 
Hormonal contraception and venous thromboembolism • S.O. Skouby (Denmark)
Congress session 7: Violence against women 
The reality of female genital mutilation in Europe • E. Leye (Belgium) 
From female genital mutilation to female genital reconstruction: a surgeon’s approach • R. Karim (the Netherlands) • J. Dekker (the Netherlands)
Congress session 8: Gaps and limitations of contraceptive research 
Developing male contraception: gap or abyss? • R. Anderson (UK) 
Lots of opponents, very few advocates • A. Furedi (UK)
Congress session 9: Multidisciplinary provision of care, task sharing 
What is task sharing? • M. Festin (WHO) 
Role of mid-level providers in abortion care • H. Kopp Kallner (Sweden)
Congress session 10: Preventive potential of contraceptive practice
The contraceptive consultation for women living with HIV – role in promoting women’s health and wellbeing as well as reducing mother to child transmission of HIV • F. Fargie (UK) 
Alcohol use identification and brief intervention in the sexual health setting – evidence and challenges • S. Mann (UK) 
Role of HPV vaccination, cytology screening and colposcopy in modern Europe – what can the contraceptive provider contribute? • E. Crighton (UK)
Congress session 11: Modern society and STI 
Attitude of patients to screening and vaccines • P. Horner (UK)
Partner tracing, notification and treatment: how? • I. Blidaru (Romania)
Congress session 12: Contraception and the treatment of medical disorders 
PCOS: intervention according to phenotypes and co-morbidity • S. Skouby (Denmark) 
Contraception in women with cardiac malformations • M. Greutmann (Switzerland)
Endometriosis • T. Römer (Germany)

Expert group sessions

ESC expert group session 1: Sexual education for different target groups
Young people with intellectual disabilities and sexuality education • C. Löfgren-Martenson (Sweden) 
Sexuality education for migrants • C. Winkelmann (Germany) 
Expert group session 2: Non-hormonal methods of contraception 
Use of fertility awareness methods: information from the internet and social media • P. Frank-Hermann (Germany) 
Female sterilisation: a thing of the past?
Pro • M. Merckx (Belgium) • Con • A. Ber (Israel)
The cost-effectiveness ratio of contraceptive methods in the European Union • M. Farris (Italy) • D. Michielsen (Belgium)
Expert group session 3: Future of hormonal and molecular contraception 
New hormonal methods: recent and on the horizon • Z. Haider (UK) 
New controversies: hormonal contraception and venous/arterial thromboembolism • A. Cagnacci (Italy) 
Expert group session 4: Abortion 

Delay in presentation • R. Ingham (UK) 
Medical versus surgical
Pro • O. Heikinheimo (Finland) • Con • E. Lopez Arregui (Spain) 
Feticide • P. Lohr (UK)

Meet the experts

Meet the experts 1: Myths and misconceptions 
Myths and misconceptions: user dependent methods • A. Gompel (France) LARC • P. Baraitser (UK)


Debate 1: Contraception and the media
W. Shields (USA) • A. Faúndes (Brazil)
Debate 2: IUS/IUD in nulliparas and adolescents
Pro • G. Bartfai (Hungary) • Con • D. Mansour (UK)


Workshop 1: Sexual and reproductive health of adolescents, a global challenge 
Sexual health of young people in the WHO European Region • E. Ketting (the Netherlands) 
Cost-effectiveness of youth-friendly SR health services • J. Kempers (the Netherlands) 
Youth-friendly clinics in Estonia – association with contraceptive use • K. Part (Estonia) 
Adolescent contraception and sexually transmitted diseases • G. Creatsas (Greece)
Workshop 2: Contraceptive behaviour change: what, who and how? 
Problematic contraceptive behaviour throughout the contraceptive cycle • C. Picavet (the Netherlands) 
Theory and intervention: What works to improve compliance and continuation • K. Sedlecky (Serbia) 
Intervention mapping: the sexuality education programme ‘Long Live Love’ • F. Mevissen (the Netherlands)

Joint sessions

Joint session 1: ESC and SEG
Androgen-restored contraception • X.Y. Zimmerman (the Netherlands) 
The fetal estrogen estetrol (E4) and the breast • G. Merki (Switzerland)
Joint session 2: ESC, Russian Society of Contraception and Russian Association for Population and Development 
Reducing unwanted pregnancies and abortions: contraceptive preferences among Russian women and the role of Ob/Gyns in exercising women’s “informed choice” • V. Prilepskaya (Russia)
The results of the RAPD project “Strengthening reproductive health and effective emergency prevention of unwanted pregnancies among certain (vulnerable) groups of the population in three regions of the Russian Federation” (2014 – 2015) • L. Erofeeva (Russia)
Joint session 3: ESC and ESSM
The ESSM educational activities and MJCSM exam The importance of gynaecologists • C. Reisman (the Netherlands)
Joint session 4: ESC and Population Council: Future user-controlled methods of contraception 
Impact of family planning research on decrease in maternal mortality • J. Townsend (USA) 
Vaginal rings as user-controlled methods • G. Creasy (USA)
Contraception during lactation • R. Merkatz (USA) 
Joint session 5: ESC, IPPF and WHO: Quality of SRH care 
Dilemmas in sexual and reproductive health care in Central Europe • J. Annus (Hungary) 
Quality of contraceptive care across Europe • L. Luyckfasseel (IPPF) 
Quality of contraceptive counseling and care – a community and healthcare providers perspective • P. Steyn (WHO)
Joint session 6: ESC, CIC and APCOC: How to deal with illegal abortion?
Impact of illegal abortion on maternal mortality • L. Bahamondes (Brazil) 
The Asian perspective on how to deal with illegal abortion by promoting contraception • J. Hassan (Malaysia, APCOC) 
Dealing with the barriers to access to abortion • R. Lertxundi Barañano (Spain, ESC) 
Joint session 7: ESC and FSRH: Education 
New frontiers in education and training • A.C. Frellsen (Denmark) 
Assessment in sexual health training • J. Heathcote (UK)
Joint session 8: ESC and SFP: Explaining the rapid decline in teen birth rates in the USA, 1985 – 2015
Interaction of US teen pregnancy, birth and abortion rates • D. Foster (USA)
Joint session 9: ESC and EBCOG Guidelines and standard of care
Is there a need for training in contraception across Europe? • G. Merki (Switzerland)
Joint session 10: ESC and FIAPAC: The good, the bad and the ugly
The good news: simplified abortion • K. Gemzell Danielsson (Sweden) 
The bad news: still restricted access to abortion • C. Fiala (Austria) 
The ugly news: delayed presentation • S. Cameron (UK)
 Joint session 11: ESC, FIGO and UNFPA Contraception a global view 
Latin American challenges and solutions in contraception • L. Bahamondes (Brazil)
Joint session 12: ESC and WHO 
The latest WHO guidelines in SRH • J. Kiarie (WHO) 
Implementation of WHO guidelines in the WHO European region • G. Lazdane (WHO) 
New guidelines on task shifting in abortion care • B. Ganatra (WHO)
Joint Session 13: ESC and DGGEF
Revival of POPS • A. Schindler (Germany)
Joint Session 15: ESC and ISPOG: Sexual health over the life course – the bio-psycho-social perspective
Sexual health care for adolescents • S. Renteria (Switzerland)
ICMC meeting: Men and contraception 
Men’s family planning needs and their willingness to take responsibility for contraception • C. Picavet (the Netherlands) 
Hormonal male contraception: new options • C. Wang (USA)


  • All presentations are protected by copyright and meant either for personal viewing or for educational purposes only.
  • All powerpoints were up to date at the time of the presentation. Be aware of scientific progress since then.
  • Reproduction of information for commercial purposes is not allowed without written permission from the ESC Central Office.
  • The content of the presentations does not always reflect the opinion of the ESC.
  • The ESC accepts no liability for the content of the presentations.